15 hrs - Translate

https://www.selleckchem.com/pr....oducts/alflutinib-as
This study aimed to investigate whether insulin resistance (IR) in individuals with type2 diabetes undergoing intensive glycemic control determines the extent of improvement in neuropathy. This was an exploratory substudy of an open-label, randomized controlled trial of individuals with poorly controlled type2 diabetes treated with exenatide and pioglitazone or insulin to achieve a glycated hemoglobin 7.0% (53mmol/mol). Baseline IR was defined using homeostasis model assessment of IR, and change in neuropathy